Literature DB >> 8824958

Clinical spectrum of Leishmaniasis.

R D Pearson1, A Q Sousa.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8824958     DOI： 10.1093/clinids/22.1.1

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  130 in total

Review 1.  Clinical and experimental advances in treatment of visceral leishmaniasis.

Authors:  H W Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  The Leishmania infantum acidic ribosomal protein LiP2a induces a prominent humoral response in vivo and stimulates cell proliferation in vitro and interferon-gamma (IFN-gamma) production by murine splenocytes.

Authors:  M Soto; C Alonso; J M Requena
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 3.  Receptor-mediated phagocytosis of Leishmania: implications for intracellular survival.

Authors:  Norikiyo Ueno; Mary E Wilson
Journal:  Trends Parasitol       Date:  2012-06-21

4.  A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis.

Authors:  I Suffia; B Ferrua; X Stien; B Mograbi; P Marty; D Rousseau; K Fragaki; J Kubar
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  Comparison of PCR assays for diagnosis of cutaneous leishmaniasis.

Authors:  Esther Bensoussan; Abedelmajeed Nasereddin; Flory Jonas; Lionel F Schnur; Charles L Jaffe
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

6.  Setting new immunobiological parameters in the hamster model of visceral leishmaniasis for in vivo testing of antileishmanial compounds.

Authors:  M A Dea-Ayuela; S Rama-Iñiguez; J M Alunda; F Bolás-Fernandez
Journal:  Vet Res Commun       Date:  2007-01-19       Impact factor: 2.459

7.  IL-1β (-511T/C) gene polymorphism not IL-1β (+3953T/C) and LT-α (+252A/G) gene variants confers susceptibility to visceral leishmaniasis.

Authors:  Ali Moravej; Manoochehr Rasouli; Mehdi Kalani; Sadaf Asaei; Simin Kiany; Sohrab Najafipour; Amin Koohpayeh; Abbas Abdollahi
Journal:  Mol Biol Rep       Date:  2012-02-05       Impact factor: 2.316

8.  Lipid bodies accumulation in Leishmania infantum-infected C57BL/6 macrophages.

Authors:  N E Rodríguez; R D Lockard; E A Turcotte; T Araújo-Santos; P T Bozza; V M Borges; M E Wilson
Journal:  Parasite Immunol       Date:  2017-06-16       Impact factor: 2.280

9.  Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection.

Authors:  S M B Jeronimo; A K B Holst; S E Jamieson; R Francis; D R A Martins; F L Bezerra; N A Ettinger; E T Nascimento; G R Monteiro; H G Lacerda; E N Miller; H J Cordell; P Duggal; T H Beaty; J M Blackwell; M E Wilson
Journal:  Genes Immun       Date:  2007-08-23       Impact factor: 2.676

10.  Preclinical diagnosis of American visceral leishmaniasis during early onset of human Leishmania (L.) infantum chagasi-infection.

Authors:  Luciana Vieira do Rêgo Lima; Patrícia Karla Santos Ramos; Marliane Batista Campos; Thiago Vasconcelos dos Santos; Claudia Maria de Castro Gomes; Márcia Dalastra Laurenti; Carlos Eduardo Pereira Corbett; Fernando Tobias Silveira
Journal:  Pathog Glob Health       Date:  2014-12-09       Impact factor: 2.894
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.